We live in a world where trade agreements and patent laws often prioritize corporate profits over people’s lives. Patent monopolies allow companies to market life-saving medicines at obscene prices.
In order to make and keep medicines affordable for those in need, we must develop regional and national strategies to challenge these intellectual property barriers. ITPC and our partners work to develop such strategies based on the real-life consequences for communities affected by HIV, helping to refocus the global trade agenda so that access to medicines is a core priority.
